InsiderTrades

Form 4 for EVH Evolent Health, Inc.

Accepted 2021-10-19 00:00:00 ET · period of report 2021-10-15 · accession 0001628908-21-000135 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-10-19 2021-10-15 EVH Blackley Seth CEO, Dir S - Sale+OE $29.86 -150.0K 204.8K -42% -$4.48M
D 2021-10-19 2021-10-15 EVH Blackley Seth CEO, Dir M - OptEx $3.84 +150.0K 354.8K +73% +$576.0K
D 2021-10-19 2021-10-15 EVH Blackley Seth CEO, Dir M - OptEx $0.00 -150.0K 186.0K -45% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-10-15 S D 150,000 $29.86 204,842 D — — (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.66 to $30.07, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
2 Common Class A Common Stock 2021-10-15 M A 150,000 $3.84 354,842 D — — (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
3 Derivative Class A Common Option (right to buy) 2021-10-15 M D 150,000 $0.00 186,040 D $3.84 · — to 2024-04-01 150,000 Class A Common Stock (F4) The Class A Common Stock Options exercised vested on December 1, 2015 and December 1, 2016.